News
Background: XMT-1522 is an ADC consisting of a novel human IgG1 anti-HER2 monoclonal antibody conjugated to an auristatin-based cytotoxic payload (AF-HPA). An average of 12 AF-HPA molecules is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback